Key Takeaways
- • Private equity firms are increasingly using joint ventures with nonprofit health systems as a primary expansion strategy across hospitals, rehabilitation facilities, ambulatory surgery centers, hospice, home health, and behavioral health sectors.
- • Research from the Private Equity Stakeholder Project (PESP) documents hundreds of healthcare facilities operating through nonprofit-private equity joint ventures, with at least 568 facilities identified as operating under this model.
- • Joint venture structures allow PE-backed healthcare companies to expand into new markets, access established referral networks and patient populations, and share financial risk—while potentially operating under different regulatory frameworks than traditional acquisitions.
- • The nonprofit joint venture model has received significantly less public scrutiny and regulatory attention than traditional private equity acquisitions, despite becoming increasingly common across the healthcare sector.
- • Federal and state oversight frameworks may not be keeping pace with the complexity of these partnership structures, raising questions about transparency and accountability in nonprofit-PE collaborations.
Summary
Private equity's healthcare expansion strategy is evolving beyond traditional acquisitions toward joint ventures with nonprofit health systems, according to research released by the Private Equity Stakeholder Project (PESP). The organization has documented hundreds of healthcare facilities operating through nonprofit-private equity partnerships, establishing this model as a significant but underexamined component of PE's healthcare footprint.
PESP executive director Jim Baker emphasized the strategic shift in PE's approach: "Private equity's healthcare playbook is evolving. Our research documents how private equity has increasingly relied on joint ventures with nonprofits to expand its presence in healthcare. These arrangements have received far less attention than traditional private equity buyouts, even as they become more common across hospitals and other healthcare sectors." The joint venture strategy spans multiple healthcare verticals, including hospitals, rehabilitation facilities, ambulatory surgery centers, hospice operations, home health services, and behavioral health providers.
For PE-backed healthcare companies, joint ventures with nonprofits offer several structural advantages. These partnerships provide market expansion opportunities into new geographic regions, grant access to established referral networks and existing patient populations, enable risk-sharing with nonprofit partners, and may involve different regulatory considerations compared to outright acquisitions. The model allows PE firms to leverage nonprofit status while maintaining operational control and financial upside—a configuration that has attracted growing interest within the PE healthcare investment community.
The PESP research raises a critical governance question: existing federal and state oversight frameworks may not adequately address the complexity inherent in nonprofit-private equity partnership structures. Unlike traditional PE acquisitions, which face clear regulatory scrutiny, joint ventures operate in a more ambiguous regulatory space where nonprofit status can obscure PE involvement and decision-making authority. This structural opacity has allowed the model to expand with minimal public attention relative to its scale and market impact.
At least 568 healthcare facilities now operate through nonprofit-private equity joint ventures, according to PESP's documentation, underscoring the material scope of this strategy. As these partnerships proliferate across the healthcare sector, questions about transparency, accountability, and regulatory adequacy have become increasingly urgent for institutional investors, policymakers, and healthcare stakeholders evaluating the implications of PE's evolving healthcare expansion playbook.
PESP executive director Jim Baker emphasized the strategic shift in PE's approach: "Private equity's healthcare playbook is evolving. Our research documents how private equity has increasingly relied on joint ventures with nonprofits to expand its presence in healthcare. These arrangements have received far less attention than traditional private equity buyouts, even as they become more common across hospitals and other healthcare sectors." The joint venture strategy spans multiple healthcare verticals, including hospitals, rehabilitation facilities, ambulatory surgery centers, hospice operations, home health services, and behavioral health providers.
For PE-backed healthcare companies, joint ventures with nonprofits offer several structural advantages. These partnerships provide market expansion opportunities into new geographic regions, grant access to established referral networks and existing patient populations, enable risk-sharing with nonprofit partners, and may involve different regulatory considerations compared to outright acquisitions. The model allows PE firms to leverage nonprofit status while maintaining operational control and financial upside—a configuration that has attracted growing interest within the PE healthcare investment community.
The PESP research raises a critical governance question: existing federal and state oversight frameworks may not adequately address the complexity inherent in nonprofit-private equity partnership structures. Unlike traditional PE acquisitions, which face clear regulatory scrutiny, joint ventures operate in a more ambiguous regulatory space where nonprofit status can obscure PE involvement and decision-making authority. This structural opacity has allowed the model to expand with minimal public attention relative to its scale and market impact.
At least 568 healthcare facilities now operate through nonprofit-private equity joint ventures, according to PESP's documentation, underscoring the material scope of this strategy. As these partnerships proliferate across the healthcare sector, questions about transparency, accountability, and regulatory adequacy have become increasingly urgent for institutional investors, policymakers, and healthcare stakeholders evaluating the implications of PE's evolving healthcare expansion playbook.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.